Reactive arthritis epidemiology and demographics

Reactive arthritis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Reactive arthritis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Reactive arthritis epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Reactive arthritis epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Reactive arthritis epidemiology and demographics
CDC on Reactive arthritis epidemiology and demographics
Reactive arthritis epidemiology and demographics in the news
Blogs onReactive arthritis epidemiology and demographics
Directions to Hospitals Treating Reactive arthritis
Risk calculators and risk factors forReactive arthritis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief:

Epidemiology and Demographics

Incidence

• The incidence of reactive arthritis following a gastrointestinal or genitourinary infection is approximately 3-27 cases per 100,000 individuals worldwide.
• The incidence rate of reactive arthritis varies with the underlying infection.
  • The incidence rate of reactive arthritis following Campylobacter infection is 900 per 100,000 cases.
  • The incidence rate of reactive arthritis following Salmonella and Shigella infection is 1200 per 100,000 cases.

Globally, the annual incidence has been reported between 0.6 to 27 per 100,000, and the prevalence is estimated to be 30 to 40 per 100,000 adults [3,4,6,14].

Prevalence

• The prevalence of reactive arthritis is approximately 0 to 40 per 100,000 individuals worldwide.
• In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
• The prevalence of [disease/malignancy] is estimated to be [number] cases annually.

Case-fatality rate/Mortality rate

• In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
• The case-fatality rate/mortality rate of [disease name] is approximately [number range].

Age

• Patients of all age groups may develop reactive arthritis.
• Reactive arthritis commonly affects young adults
• [Chronic disease name] is usually first diagnosed among [age group].
• [Acute disease name] commonly affects [age group].

Race

• There is no racial predilection to [disease name].
• [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].

Gender

• Reactive arthritis affects men and women equally.
• [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.

Region

• The majority of [disease name] cases are reported in [geographical region].

• [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].